Bionano Genomics, Inc. (BNGO) Quick Ratio
- Quick ratio · latest quarter: Value 1.42×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 1.42× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. $14.29M ÷ $10.04M ≈ 1.42× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 14.29M USD | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 10.04M USD | Liabilities, Current |
| Cash and equivalents | 3.73M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 6.19M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | 4.37M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 7.01M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $14.29M | $10.04M | $3.73M | $6.19M | $4.37M | $7.01M | 1.42× |
| 2026-03-31 | $18.54M | $21.23M | $3.42M | $10.98M | $4.13M | $7.69M | 0.87× |
| 2025-12-31 | $24.47M | $22.94M | $2.99M | $16.28M | $5.20M | $7.83M | 1.07× |
| 2025-09-30 | $26.11M | $22.98M | $3.06M | $18.52M | $4.53M | $8.42M | 1.14× |
| 2025-06-30 | $19.93M | $24.18M | $3.56M | $12.88M | $3.49M | $10.31M | 0.82× |
| 2025-03-31 | $21.59M | $26.41M | $3.63M | $14.61M | $3.35M | $11.42M | 0.82× |
| 2024-12-31 | $14.23M | $37.34M | $9.17M | $302.00K | $4.75M | $13.28M | 0.38× |
| 2024-09-30 | $17.27M | $32.95M | $8.79M | $3.16M | $5.32M | $16.28M | 0.52× |
| 2024-06-30 | $25.20M | $37.17M | $10.43M | $8.52M | $6.25M | $23.15M | 0.68× |
| 2024-03-31 | $36.63M | $58.51M | $15.76M | $12.56M | $8.31M | $23.80M | 0.63× |
| 2023-12-31 | $76.09M | $100.03M | $17.95M | $48.82M | $9.32M | $27.60M | 0.76× |
| 2023-09-30 | $72.25M | $40.19M | $34.57M | $29.01M | $8.67M | $33.51M | 1.80× |
| 2023-06-30 | $84.67M | $33.50M | $14.86M | $62.21M | $7.61M | $32.45M | 2.53× |
| 2023-03-31 | $102.59M | $38.13M | $4.10M | $91.70M | $6.78M | $33.11M | 2.69× |
| 2022-12-31 | $120.21M | $35.88M | $5.09M | $108.09M | $7.02M | $29.76M | 3.35× |
| 2022-09-30 | $186.02M | $33.50M | $28.17M | $152.02M | $5.83M | $25.05M | 5.55× |
| 2022-06-30 | $192.19M | $27.91M | $27.16M | $160.18M | $4.85M | $20.59M | 6.89× |
| 2022-03-31 | $221.98M | $18.66M | $24.05M | $192.42M | $5.51M | $16.27M | 11.90× |
| 2021-12-31 | $255.55M | $21.84M | $24.57M | $226.04M | $4.93M | $12.39M | 11.70× |
| 2021-09-30 | $329.06M | $17.70M | $140.74M | $185.33M | $3.00M | $9.02M | 18.59× |
| 2021-06-30 | (m) | $10.73M | $332.55M | (m) | $2.84M | $4.89M | (m) |
| 2021-03-31 | (m) | $7.17M | $362.06M | (m) | $1.99M | $3.04M | (m) |
| 2020-12-31 | (m) | $8.94M | $38.45M | (m) | $2.78M | $3.32M | (m) |
| 2020-09-30 | (m) | $24.78M | $18.87M | (m) | $3.86M | $4.59M | (m) |
| 2020-06-30 | (m) | $19.51M | $17.19M | (m) | $3.25M | $3.29M | (m) |
| 2020-03-31 | (m) | $23.19M | $8.14M | (m) | $4.12M | $3.61M | (m) |
| 2019-12-31 | (m) | $26.37M | $17.31M | (m) | $6.33M | $3.44M | (m) |
| 2019-09-30 | (m) | $7.44M | $8.22M | (m) | $6.00M | $2.60M | (m) |
| 2019-06-30 | (m) | $7.54M | $15.29M | (m) | $4.98M | $3.02M | (m) |
| 2019-03-31 | (m) | $4.71M | $20.83M | (m) | $4.06M | $1.41M | (m) |
| 2018-12-31 | (m) | $4.52M | $16.52M | (m) | $4.51M | $1.07M | (m) |
| 2018-09-30 | (m) | $5.51M | $20.66M | (m) | $4.00M | $2.61M | (m) |
| 2017-12-31 | (m) | $16.65M | $1.02M | (m) | $3.35M | $1.69M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |